In the output interface, eRNA-Anno revealed that both CCAT1 and LINC02257 exhibited higher expression levels in colorectal cancer (Figure 4A) and showed enriched active enhancer markers (Figure 4B), which is consistent with previous studies [47,48]. Here, LINC01705 is linked to colorectal cancer.